Clinical trial
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric…
NCT00272792 · BioMarin Pharmaceutical, Industry · Completed
Key facts
| NCT number | NCT00272792 |
|---|---|
| Title | Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet |
| Official title | A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet |
| Lead sponsor | BioMarin Pharmaceutical, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Phenylketonurias |
| Intervention type | Drug |
| Interventions | Sapropterin Dihydrochloride, Placebo |
| Enrollment | 45 |
| Start date | Feb 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Jan 9, 2006 |
| Last update posted | Aug 13, 2015 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: